Stay updated on Adjunctive Ganaxolone in PCDH19 Epilepsy Clinical Trial

Sign up to get notified when there's something new on the Adjunctive Ganaxolone in PCDH19 Epilepsy Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Adjunctive Ganaxolone in PCDH19 Epilepsy Clinical Trial page

  1. Check
    5 days ago
    Change Detected
    Summary
    Site revision updated from v3.4.2 to v3.4.3.
    Difference
    0.1%
    Check dated 2026-03-12T03:24:29.000Z thumbnail image
  2. Check
    12 days ago
    No Change Detected
  3. Check
    19 days ago
    No Change Detected
  4. Check
    34 days ago
    Change Detected
    Summary
    A new Revision: v3.4.2 is displayed and an earlier government-funding status notice was removed. The study content, eligibility criteria, and outcome measures remain unchanged.
    Difference
    0.4%
    Check dated 2026-02-11T14:11:45.000Z thumbnail image
  5. Check
    41 days ago
    Change Detected
    Summary
    Added a government funding notice banner with links to cc.nih.gov and opm.gov. Updated the site software to Revision: v3.4.1, replacing v3.4.0.
    Difference
    0.4%
    Check dated 2026-02-04T10:40:06.000Z thumbnail image
  6. Check
    48 days ago
    Change Detected
    Summary
    Show glossary toggle added and revision/version information updated. Minor capitalization changes to data labels, such as 'Last Update Submitted that Met QC Criteria' and 'No FEAR Act Data'.
    Difference
    0.2%
    Check dated 2026-01-28T06:39:27.000Z thumbnail image
  7. Check
    62 days ago
    Change Detected
    Summary
    Footer now shows Revision: v3.3.4 (replacing v3.3.3); core study content and data remain unchanged. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.1%
    Check dated 2026-01-14T02:39:56.000Z thumbnail image
  8. Check
    84 days ago
    Change Detected
    Summary
    Updated the study page to revision v3.3.3 with a reorganized Locations section listing new site locations (Arkansas, California, North Carolina, Pennsylvania, Utah). The HHS Vulnerability Disclosure link was removed.
    Difference
    0.6%
    Check dated 2025-12-23T14:27:44.000Z thumbnail image

Stay in the know with updates to Adjunctive Ganaxolone in PCDH19 Epilepsy Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Adjunctive Ganaxolone in PCDH19 Epilepsy Clinical Trial page.